BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olfa G, Christophe C, Philippe L, Romain S, Khaled H, Pierre H, Odile B, Jean-Christophe D. RUNX2 regulates the effects of TNFalpha on proliferation and apoptosis in SaOs-2 cells. Bone 2010;46:901-10. [PMID: 20053387 DOI: 10.1016/j.bone.2009.12.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nikolajević J, Šabovič M. Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease. Int J Mol Sci 2023;24. [PMID: 36834544 DOI: 10.3390/ijms24043132] [Reference Citation Analysis]
2 Maiso P, Mogollón P, Ocio EM, Garayoa M. Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression. Cancers (Basel) 2021;13:2542. [PMID: 34067236 DOI: 10.3390/cancers13112542] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ling Z, Fan G, Yao D, Zhao J, Zhou Y, Feng J, Zhou G, Chen Y. MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2. Exp Ther Med 2020;19:481-8. [PMID: 31897096 DOI: 10.3892/etm.2019.8231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Perego S, Sansoni V, Banfi G, Lombardi G. Sodium butyrate has anti-proliferative, pro-differentiating, and immunomodulatory effects in osteosarcoma cells and counteracts the TNFα-induced low-grade inflammation. Int J Immunopathol Pharmacol 2018;32:394632017752240. [PMID: 29363375 DOI: 10.1177/0394632017752240] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
5 Douglas TE, Vandrovcová M, Kročilová N, Keppler JK, Zárubová J, Skirtach AG, Bačáková L. Application of whey protein isolate in bone regeneration: Effects on growth and osteogenic differentiation of bone-forming cells. Journal of Dairy Science 2018;101:28-36. [DOI: 10.3168/jds.2017-13119] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
6 Liang GH, Liu N, He MT, Yang J, Liang ZJ, Gao XJ, Rahhal AH, He QY, Zhang HT, Zha ZG. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling. J Cell Biochem 2018;119:948-59. [PMID: 28681940 DOI: 10.1002/jcb.26260] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
7 Roos A, Satterfield L, Zhao S, Fuja D, Shuck R, Hicks MJ, Donehower LA, Yustein JT. Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis. Br J Cancer 2015;113:1289-97. [PMID: 26528706 DOI: 10.1038/bjc.2015.305] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
8 Sun SS, Zhang L, Yang J, Zhou X. Role of runt-related transcription factor 2 in signal network of tumors as an inter-mediator. Cancer Lett 2015;361:1-7. [PMID: 25727319 DOI: 10.1016/j.canlet.2015.02.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Mortus JR, Zhang Y, Hughes DP. Developmental pathways hijacked by osteosarcoma. Adv Exp Med Biol 2014;804:93-118. [PMID: 24924170 DOI: 10.1007/978-3-319-04843-7_5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
10 Zhang YH, Li B, Shen L, Shen Y, Chen XD. The role and clinical significance of YES-associated protein 1 in human osteosarcoma. Int J Immunopathol Pharmacol 2013;26:157-67. [PMID: 23527718 DOI: 10.1177/039463201302600115] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
11 Roodman GD. Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Rev 2012;31:569-78. [PMID: 22706844 DOI: 10.1007/s10555-012-9372-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
12 Deschaseaux F, Gaillard J, Langonné A, Chauveau C, Naji A, Bouacida A, Rosset P, Heymann D, De Pinieux G, Rouas‐freiss N, Sensébé L. Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB j 2013;27:2977-87. [DOI: 10.1096/fj.13-227264] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
13 Vallet S, Raje N. Bone anabolic agents for the treatment of multiple myeloma. Cancer Microenviron. 2011;4:339-349. [PMID: 22139744 DOI: 10.1007/s12307-011-0090-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
14 Martin JW, Zielenska M, Stein GS, van Wijnen AJ, Squire JA. The Role of RUNX2 in Osteosarcoma Oncogenesis. Sarcoma 2011;2011:282745. [PMID: 21197465 DOI: 10.1155/2011/282745] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 6.5] [Reference Citation Analysis]